Condition
Hypoxic Ischemic Brain Injury
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 2 (1)
Trial Status
Terminated1
Not Yet Recruiting1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT02793999RecruitingPrimary
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
NCT06985290Phase 2Not Yet RecruitingPrimary
Dexmedetomidine Versus Morphine During Cooling Therapy in Neonates
NCT02836340Phase 1Terminated
TIBOHCA: Safety, Tolerability and Pharmacokinetics of 2-Iminobiotin (2-IB) After OHCA
Showing all 3 trials